With a high sensitivity for detecting disease recurrence, follow-up imaging using PET/CT may help to more successfully guide the management of patients with non-Hodgkin lymphoma (NHL) who are at risk for disease recurrence, according to the results of a study presented during the 2015 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (abstract 599). {read more here}

Clinicians may soon be able to add PET/MRI with F-18 fluorodopa (FDOPA) to their imaging arsenal to evaluate the efficacy of the angiogenesis inhibitor bevacizumab for pediatric brain tumors, according to a study presented on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. {read more here}

Attempts to impact the ICD-10 transition keep coming with a third attempt in about a month now aiming to provide a two-year grace period for providers submitting claims. {read more here}

A newly developed technique leverages integrin imaging and multi-bed-position dynamic PET acquisition to create advanced whole-body parametric maps, which could help evaluate tumors and metastases throughout the body, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 annual meeting in Baltimore. {read more here}